A patient diagnosed with preeclampsia is admitted to the hospital and prescribed magnesium sulfate therapy.
What is the purpose of administering magnesium sulfate to this patient?
To decrease her blood pressure.
To decrease her tidal volume.
To prevent her from becoming dehydrated.
To prevent her from having convulsions.
The Correct Answer is D
The correct answer is choice D: To prevent her from having convulsions. Magnesium sulfate is a mineral that reduces seizure risks in women with preeclampsia, a condition of high blood pressure and protein in the urine during pregnancy. Magnesium sulfate can lower the cerebral perfusion pressure and prevent convulsions. However, magnesium sulfate does not affect the neonatal outcomes and can cause side effects such as respiratory depression.
Choice A is wrong because magnesium sulfate does not decrease blood pressure. It is used along with medications that help reduce blood pressure.
Choice B is wrong because magnesium sulfate does not decrease tidal volume. It can cause respiratory depression if the serum level is too high.
Choice C is wrong because magnesium sulfate does not prevent dehydration. It can cause fluid retention and pulmonary edema if given in excess.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
The correct answer is choice C. Assess the client’s blood pressure.Methylergonovine is a uterotonic medication that can cause hypertension and is contraindicated for clients with preeclampsia or cardiac disease.
Therefore, the nurse should check the client’s blood pressure before administering this medication to ensure it is within normal range (120/80 mm Hg or lower).
Choice A is wrong because assessing the client’s pain scale is not a priority assessment before giving methylergonovine.
Pain is not a contraindication for this medication and does not affect its effectiveness.
Choice B is wrong because assessing the client’s respiratory rate is not a priority assessment before giving methylergonovine.
Respiratory rate is not affected by this medication and does not indicate any adverse effects.
Choice D is wrong because assessing the client’s last bowel movement is not a priority assessment before giving methylergonovine.
Bowel movement is not related to postpartum hemorrhage or uterine atony, which are the indications for this medication.
Correct Answer is D
Explanation
The correct answer is choice D: “This test is used to identify fetal abnormalities.” Alpha-fetoprotein (AFP) is a protein produced by the fetus that can be measured in the mother’s blood.
Abnormal levels of AFP may indicate a problem with the development of the baby’s brain, spine, or other organs.
This test is usually done between 15 and 20 weeks of gestation.
Choice A is wrong because AFP does not measure the baby’s maturity.
It is not related to the gestational age or the lung development of the fetus.
Choice B is wrong because AFP is not a routine test for all pregnant women over thirty years of age.
It is an optional screening test that may be offered to women who have a higher risk of having a baby with a birth defect, such as those who have a family history, a previous affected pregnancy, or certain ethnic backgrounds.
Choice C is wrong because AFP is not recommended for people with a history of infertility.
It does not assess the fertility status of the mother or the father.
It only measures the level of a fetal protein in the mother’s blood.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.